hahahaha, we'll see. Watch and see how long this deal has been in the works once it's announced. BTW, Leronlimabs numbers in the trials speak volumes to the GSK analysts. Tick tock.... I wonder who else is bidding for Leronlimab???
If one company (gsk) were to buy another (cydy), why would it matter if they were broke since the asset (LL) would be the consideration? In the examples given, they were not purchasing those companies’ cash… smh… Bueller? Bueller?
News 
Market Data 
Discover 
